BMJ talk medicine

Claire Mulrenan, specialist registrar in public health, and Mark Petticrew, professor of public health evaluation, both working at the London School of Hygiene and Tropical medicine were surprised to see high-fat, high-salt fast food brands being featured heavily on the website of one of the UK's most beloved children's comics.

In this podcast, they describe why they think that is harmful, and why the Beano should think again about its editorial policies, to protect children's health.

To read the full investigation:
www.bmj.com/content/380/bmj.p197

Reproductive coercion may feel like something that we don’t see very often in general practice, but a 2022 poll carried out for BBC Radio 4 of 1,060 UK women between the ages of 18 and 44 found that half of them had experienced some form of reproductive coercion. This week, we speak to returning guest Annabel Sowemimo about the various forms that reproductive coercion can take, and who might be at risk of experiencing it. We discuss how we, as GPs, can identify these patients, and, once we’ve done so, how we might be able to help them. Later on, we talk to our BMJ columnist, John Launer, about how narrative medicine approaches can help to reach a better & more satisfying resolution to a consultation “puzzle” for you and for the patient.

Our guests:

Annabel Sowemimo is a community sexual health registrar, based in Leicester. She is also a PhD candidate at King’s College London, and is the co-founder of the charity Reproductive Justice Initiative.

John Launer is a GP educator, working for Health Education England. He is also a freelance educator and writer, as well as being a columnist for ‘The BMJ’.

Further reading:

‘How to recognise and respond to reproductive coercion’. BMJ 2022;378:e069043. https://www.bmj.com/content/378/bmj-2021-069043

‘John Launer: The art of paying attention’. BMJ 2022;378:o2294. https://www.bmj.com/content/378/bmj.o2294

‘Careful, kind care is our compass out of the pandemic fog’. BMJ 2022;379:e073444. https://www.bmj.com/content/379/bmj-2022-073444

We’ve talked before about how one's own experience of illness can affect their practice, but does it also influence how much you share with your patients?

In today’s episode we’re going to be talking all about physician self-disclosure - that is, all the things we, as future doctors, might share with our patients. We’ll be asking how appropriate it is to share your own stories with a patient and how you know when the timing is right to do this. This week, we’re going to be focusing on stories of illness and health, but we’ll come on to talking about other aspects of our identity in a future episode.

Expert guests:

Dr John Launer is a medical educator and writer. His background is in general practice and family therapy, and he also has a degree in English literature. He now devotes his time to medical education and he specialises in interactional skills.

Check us out on social media:

Twitter: https://twitter.com/BMJStudent

Instagram: https://www.instagram.com/bmj_student/

Facebook: https://www.facebook.com/BMJStudent/

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.

ADC Fetal and Neonatal’s Associate Editor, Jonathan Davis, and the Edition Editor of the journal, Ben Stenson, discuss the highlights from the January 2023 issue. The Fantoms article: https://fn.bmj.com/content/108/1/1

Additional links:

Helix trial: https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00264-3/fulltext

Premiloc study: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)00202-6/fulltext

SToP BPD study: https://jamanetwork.com/journals/jama/fullarticle/2722773

Early amino acids in preterm infants and neurodisability at 2 years: https://www.nejm.org/doi/full/10.1056/NEJMoa2204886?query=recirc_curatedRelated_article

Commentary on early amino acid study: https://www.nejm.org/doi/full/10.1056/NEJMe2212522

Commentary on steroids and risk modification: https://fn.bmj.com/content/103/6/F500

Neoprom metaanalysis - https://pubmed.ncbi.nlm.nih.gov/29872859/

Boost II trial - https://www.nejm.org/doi/full/10.1056/nejmoa1514212

Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832

The best of the papers from our February 2023 issue, covered by Sarah Edwards and Rick Body. This month we cover great papers on COVID-19 and wellbeing, domestic violence and the diagnosis of testicular torsion.

Read the highlights: https://emj.bmj.com/content/40/2/83.

You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.

If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244).

Thank you for listening!

Practical Neurology Editors Phil Smith and Geraint Fuller talk you through the highlights of the February 2023 issue of the journal (https://pn.bmj.com/content/23/1/1).

Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.

If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053).

The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole.

Thank you for listening.

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the February 2023 issue of DTB. They discuss concerns over a national initiative in England to transfer people with atrial fibrillation to edoxaban from other DOACs (https://dtb.bmj.com/content/61/2/18). They review a study that examined whether the correct dose of DOAC was used in people with renal impairment (https://dtb.bmj.com/content/61/2/21). They talk about the use of empagliflozin in people with heart failure (https://dtb.bmj.com/content/61/2/22) and finish with an overview of an article that discusses prescribing for pregnancy for those with inflammatory rheumatic disease (https://dtb.bmj.com/content/61/2/24).

60th anniversary interview with Dr John Dowden: https://soundcloud.com/bmjpodcasts/dtb-60th-anniversary-podcast-interview-john-dowden

Trends in direct oral anticoagulant (DOAC) prescribing in English primary care (2014–2019): https://heart.bmj.com/content/109/3/195

The contact address for the DTB team is [email protected].

Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.

Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Fredrik Bäckhed, The Wallenberg Laboratory, Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden on the paper '6α-hydroxylated bile acids mediate TGR5 signalling to improve glucose metabolism upon dietary fiber supplementation in mice' published in paper copy in Gut in February 2023, and available online: https://gut.bmj.com/content/72/2/314

Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).

In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Bettina Heidecker from Berlin to discuss all aspects of myocarditis. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

Link to published paper: https://heart.bmj.com/content/108/18/1486.full

In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Professors Jacobus Pfisterer and Philipp Harter to discuss prolonged maintenance with bevacizumab. Prof. Philipp Harter is the director of the Department of Gynecology & Gynecologic Oncology at Kliniken Essen-Mitte in Essen, Germany and the chair of the AGO Study Group. Prof. Jacobus Pfisterer is Director of the Gynecologic Oncology Center in Kiel Germany and former chair of the AGO Study Group.

Highlights:

- 30-month bevacizumb maintenance does not improve progression-free survival nor overall survival in advanced ovarian cancer.

- 30-month bevacizumb maintenance is associated with more adverse events compared to 15 months.

- 15-month bevacizumb maintenance remains standard of care.